Walvax Biotechnology Co., Ltd. (SHE:300142)
12.88
+0.23 (1.82%)
Apr 8, 2026, 3:04 PM CST
11.13% (1Y)
| Market Cap | 20.23B +4.3% |
| Revenue (ttm) | 2.42B -14.3% |
| Net Income | 177.74M +25.0% |
| EPS | 0.11 +25.0% |
| Shares Out | 1.60B |
| PE Ratio | 113.86 |
| Forward PE | 74.41 |
| Dividend | 0.16 (1.23%) |
| Ex-Dividend Date | Jan 9, 2026 |
| Volume | 55,218,002 |
| Average Volume | 43,267,855 |
| Open | 12.80 |
| Previous Close | 12.65 |
| Day's Range | 12.45 - 12.97 |
| 52-Week Range | 9.70 - 14.65 |
| Beta | 0.47 |
| RSI | 56.27 |
| Earnings Date | Mar 28, 2026 |